Hypophysectomy inhibits the synthesis of tumor necrosis factor α by rat macrophages: Partial restoration by exogenous growth hormone or interferon ϒ

Endocrinology

Volumn 128, Issue 2, 1991, Pages 989-996

  Edwards, Carl K ^a,e   Lorence, Robert M ^a,b,c,f   Dunham, Diane M ^a   Arkins, Sean ^a   Yunger, Libby M ^a   Greager, John A ^b,c   Walter, Robert J ^b,c   Dantzer, Robert ^d   Kelley, Keith W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Hektoen Institute for Medical Research   (United States)

^d INSERM   (France)

^e Marion Merrell Dow ^*  (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GROWTH HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; HYPOPHYSECTOMY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; FEMALE; GROWTH HORMONE; HYPOPHYSECTOMY; INTERFERON TYPE II; MACROPHAGES; MICE; MICE, INBRED BALB C; NECROSIS; NEOPLASMS, EXPERIMENTAL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0026073387     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo-128-2-989     Document Type: Article

References (57)

1. Dunn AJ 1990 Interleukin-1 as a stimulator of hormone secretion. Prog NeuroEndocrinlmmunol 3:26-34
2. Scarborough DE 1990 Cytokine modulation of pituitary hormone secretion. Proc NY Acad Sci 594:169-187
3. Beutler B, Cerami A 1986 Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320:584-588
4. Oliff A 1988 The role of tumor necrosis factor (cachectin) in cachexia. Cell 54:141-142
5. Beutler B, Cerami A 1988 Cachectin (tumor necrosis factor): A macrophage hormone governing cellular metabolism and inflammatory response. Endocr Rev 9:57-66
6. Creasey AA, Reynolds MT, Laird W 1986 Cures and partial re-gresssion of murine and human tumors by recombinant human tumor necrosis factor. Cancer Res 46:5687-5690
7. Tracey KJ, Wei H, Magogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A, Lowry SF 1988 Cach- ectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 167:1211-1220
8. Esparza I, Mannel D, Ruppel A, Falk W, Krammer PH 1987 Interferon-7 and lymphotoxin or tumor necrosis factor act syner- gistically to induce macrophage killing of tumor cells and schisto- somila of Schistosoma monsoni. J Exp Med 166:589-594
9. Kierszenbaum F, Wirth JJ 1988 Recombinant tumor necrosis factor enhances macrophage destruction of Trypanosoma cruzi in the presence of bacterial endotoxin. J Immunol 141:286-288
10. Kohler PO, O’Malley BW, Rayford PL, Lipsett MB, Odell WD 1967 Effect of pyrogen on blood levels of pituitary trophic hormones. Observations of the usefulness of the growth hormone response in the detection of pituitary disease. J Clin Endocrinol Metab 27:219-226
11. Frohman LA, Horton ES, Lebovitz HE 1967 Growth hormone releasing action of a Pseudomonas endotoxin (Piromen). Metabolism 16:57-67
12. Michie HR, Spriggs DR, Manogue KR, Sherman ML, Revhaug A, O’Dwyer ST, Arthur K, Dinarello CA, Cerami A, Wolff SM, Kuge DW, Wilmore DW 1988 Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104:280-286
13. Sharp BM, Matta SG, Peterson K, Newton R, Chao C, McAllen K 1989 Tumor necrosis factor-α is a potent ACTH secretagogue: Comparison to interleukin-1β. Endocrinology 124:3131-3133
14. Milenkovic L, Rettori V, Snyder GD, Beutler B, McCann SM 1989 Cachectin alters anterior pituitary hormone release by a direct action in vitro. Proc Natl Acad Sci USA 86:2418-2422
15. Gaillard RC, Turnill D, Sappino P, Muller AF 1990 Tumor necrosis factor a inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology 127:101-106
16. Suda, T, Tozawa F, Ushiyama T, Tomori N, Sumitomo T, Naka- gami Y, Yamada M, Demura H, Shizume K 1989 Effects of protein kinase-C-related adrenocorticotropin secretagogues and interleu- kin-1 on proopiomelanocortin gene expression in rat anterior pi-tuitary cells. Endocrinology 124:1444-1449
17. 2and cAMP independent manner. Neuroendocrinology 48:160-166
18. Pang X, Hershman JM, Mirell CJ, Pekary AE 1989 Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-alpha (cachectin). Endocrinology 125:76-84
19. Walton PE, Cronin MJ 1989 Tumor necrosis factor-α inhibits growth hormone secretion from cultured anterior pituitary cells. Endocrinology 125:925-929
20. ϒreduce prolactin release in vitro. Am J Physiol, 259 lEndocrinol Metab 22-.E672-E676.
21. 2and glucocorticoids on the pro-duction of tumor necrosis factor-a. J Leuk Biol 48:473-481
22. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A 1986 Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 232:977-980
23. Kelley KW 1989 Growth hormone, lymphocytes and macrophages. Biochem Pharmacol 38:705-713
24. Edwards III CK, Ghiasuddin SM, Schepper JM, Yunger LM, Kelley KW 1988 A newly defined property of somatotropin: Priming macrophages for production of superoxide anion. Science 239:769-771
25. Davila DR, Edwards III CK, Arkins S, Simon J, Kelley KW 1990 Interferon-7-induced priming for secretion of superoxide anion and tumor necrosis factor-a declines in macrophages from aged rats. FASEB J 4:2906-2911
26. Kelley KW, Brief S, Westly HJ, Novakofski J, Bechtel PJ, Simon J, Walker EB 1986 GH3 pituitary adenoma implants can reverse thymic aging. Proc Natl Acad Sci USA 83:5663-5667
27. Parlow AF, Wilhelm AE, Richert Jr LE 1965 Further studies on the fractionation of human pituitary glands. Endocrinology 77:1126-1134
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
29. Mosmann T 1983 Rapid colorimetrie assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
30. Espevik T, Nissen-Meyer J 1986 A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxicity factor/tumor necrosis factor from human monocytes. J Immunol Methods 95:99-105
31. Rood, PA, Lorence RM, Kelley KW 1990 Serine protease inhibitor abrogation of Newcastle disease virus enhancement of cytolysis by tumor necrosis factors-α and -β. J Natl Cancer Inst 82:213-217
32. Lorence RM, Rood PA, Kelley KW 1988 Newcastle disease virus as an antineoplastic agent: Induction of tumor necrosis factor-α and augmentation of its cytotoxicity. J Natl Cancer Inst 80:1305-1312
33. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B 1975 An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666-3670
34. 1987 SAS User’s Guide: Statistics. SAS Institute, Cary
35. Berczi I 1986 Pituitary malfunction and immune abnormalities. In: Joyner SP (ed) Pituitary Function and Immunity. CRC Press, Boca Raton, pp 42-47
36. Lorence RM, Edwards III CK, Walter RJ, Kelley KW, Greager JA 1990 In vivo effects of interferon-7: Augmentation of endotoxin- induced necrosis of tumors and priming of macrophages for tumor necrosis factor-a production. Cancer Letters 53:223-229
37. Saxena QB, Saxena RK, Adler WH 1982 Regulation of natural killer activity in vivo. III. Effect of hypophysectomy and growth hormone treatment on the natural killer activity of the mouse spleen cell population. Int Arch Allergy Appi Immunol 67:169-174
38. Bernton EW, Meitzer MS, Holaday JW 1988 Suppression of macrophage activation and T-lymphocyte function in hypoprolacti- nemic mice. Science 239:401-404
39. Urban JL, Shepard HM, Rothstein JL 1986 Tumor necrosis factor: A potent effector molecule for tumor cell killing by activated macrophages. Proc Natl Acad Sci USA 83:5233-5237
40. Daughaday WH 1977 Hormonal regulation of growth by somatotropin and other tissue growth factors. Clin Endocrinol Metab 6:117-135
41. Binz K, Joller P, Froesch P, Binz H, Zapf J, Froesch ER 1990 Repopulation of the atrophied thymus in diabetic rats by insulinlike growth factor I. Proc Natl Acad Sci USA 87:3690-3694
42. Merchav S, Tatarsky I, Hochberg Z 1988 Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone. J Clin Invest 81:791-797
43. Roldan A, Charreau E, Schillaci R, Eugui EM, Allison AC 1989 Insulin-like growth factor-1 increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin. Immunol Lett 20:5-8
44. Nagaoka I, Trapnell BC, Crystal RG 1990 Regulation of insulinlike growth factor I gene expression in the human macrophage-like cell line U937. J Clin Invest 85:448-455
45. Weigent DA, Baxter JB, Wear WE, Smith LR, Bost KL, Blalock JE 1988 Production of immunoreactive growth hormone by mono-nuclear leukocytes. FASEB J 2:2812-2818
46. Chaudhri G, Clark IA 1989 Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor. J Immunol 143:1290-1294
47. Bertini R, Bianchi M, Ghezzi P 1988 Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J Exp Med 167:1708-1712
48. Holaday JW, D’Amato RJ, Ruvio BA, Feuerstein G, Faden AI 1983 Adrenalectomy blocks pressor responses to naloxone in endotoxic shock: Evidence for sympathomedullary involvement. Circ Shock 11:201-210
49. Mealy K, van Lanschot JJB, Robinson BG, Rounds J, Wilmore DW 1990 Are the catabolic effects of tumor necrosis factor mediated by glucocorticoids? Arch Surg 125:42-48
50. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA 1988 Interleukin 1 induces a shock-like state in rabbits: Synergism with tumor necrosis factor and the effect of cycloooxygenase inhibition. J Clin Invest 81:1162-1172
51. Waage A, Espevik T 1988 Interleukin 1 potentiates the lethal effect of tumor necrosis factor a/cachectin in mice. J Exp Med 167:1987-1992
52. Bradley SF, Vibhagool A, Kunkel SL, Kauffman CA 1989 Monokine secretion in aging and malnutrition. J Leuk Biol 45:510-514
53. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming A, Bain RP 1981 Impaired growth hormone secretion in the adult population: Relation to age and adiposity. J Clin Invest 67:1361-1369
54. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE 1990 Effects of human growth hormone in men over 60 years of age. N Engl J Med 323:1-6
55. Kiess W, Butenandt O 1985 Specific growth hormone receptors on human peripheral mononuclear cells: Reexpression, identification, and characterization. J Clin Endocrinol Metab 60:740-746
56. Nagy E, Berczi I 1978 Immunodeficiency in hypophysectomized rats. Acta Endocrinol (Copenh) 89:530-537
57. Nagy E, Berczi I, Friesen HG 1983 Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol (Copenh) 102:351-357